Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 20.74
-0.53 (-2.49%)
Jun 2, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 4.19 billion as of June 2, 2026. Its market cap has increased by 14.34% in one year.
Market Cap
4.19B
Enterprise Value
3.93B
Revenue
1.74B
Ranking
n/a
PE Ratio
14.64
Stock Price
20.74
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 4.19B, a decrease of -38.77%. That is a compound annual growth rate of -8.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 4.29B | 2.71% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Wecome Pharmaceutical Company | 4.53B |
| Jiangsu Bioperfectus Technologies | 4.45B |
| Lifecome Biochemistry | 4.42B |
| Assure Tech (Hangzhou) | 4.35B |
| ChemPartner PharmaTech | 4.34B |
| Beijing Scitop Bio-tech | 4.26B |
| Kexing Biopharm | 4.16B |
| Beijing Bohui Innovation Biotechnology Group | 4.15B |